REVENUE RECOGNITION AND RELATED ALLOWANCES (Tables)

9 Months Ended

Sep. 30, 2018

Revenue Recognition [Abstract]

Disaggregation of Revenue

The following table depicts the disaggregation of revenue according to contract type:

	Three Months Ended				Nine Months Ended
(in thousands)	September 30,    2018		September 30,   2017		September 30,    2018		September 30,    2017
Sales of generic pharmaceutical products	$	30,287	$	30,546	$	83,716	$	88,608
Sales of branded pharmaceutical products		14,589		15,688		41,714		35,398
Sales of contract manufactured products		2,826		1,829		5,450		5,151
Royalties from licensing agreements		2,409		-		12,560		-
Product development services		288		-		288		-
Other(1)		304		101		726		399
Total net revenues	$	50,703	$	48,164	$	144,454	$	129,556

(1) Primarily includes laboratory services and royalties on sales of contract manufactured products

Second Disaggregation Of Revenue

The following table depicts revenue recognized during the following periods:

	Three Months Ended				Nine Months Ended
(in thousands)	September 30,    2018		September 30,   2017		September 30,    2018		September 30,    2017
Performance obligations transferred at a point in time	$	50,415	$	48,164	$	144,166	$	129,556
Performance obligations transferred over time		288		-		288		-
Total	$	50,703	$	48,164	$	144,454	$	129,556

Schedule of Valuation and Qualifying Accounts Disclosure

The following table summarizes activity in the consolidated balance sheets for accruals and allowances for the nine months ended September 30, 2018 and 2017, respectively:

(in thousands)	Accruals for Chargebacks, Rebates, Returns, and Other Allowances
										Administrative			Prompt
				Government						Fees and Other			Payment
	Chargebacks			Rebates			Returns			Rebates			Discounts
Balance at December 31, 2016	$	26,785		$	5,891		$	5,756		$	3,550		$	1,554
Accruals/Adjustments		133,849			7,807			8,949			16,840			5,960
Credits Taken Against Reserve		(134,412	)		(7,943	)		(6,388	)		(15,448	)		(5,617	)
Balance at September 30, 2017	$	26,222		$	5,755		$	8,317		$	4,942		$	1,897
Balance at December 31, 2017	$	28,230		$	7,930		$	8,274		$	5,226		$	1,834
Accruals/Adjustments		170,533			8,097			10,942			23,148			6,744
Credits Taken Against Reserve		(156,750	)		(7,013	)		(8,376	)		(21,418	)		(6,373	)
Balance at September 30, 2018	$	42,013		$	9,014		$	10,840		$	6,956		$	2,205